US20050049671A1 - Combined shaped balloon and stent protector - Google Patents

Combined shaped balloon and stent protector Download PDF

Info

Publication number
US20050049671A1
US20050049671A1 US10/894,946 US89494604A US2005049671A1 US 20050049671 A1 US20050049671 A1 US 20050049671A1 US 89494604 A US89494604 A US 89494604A US 2005049671 A1 US2005049671 A1 US 2005049671A1
Authority
US
United States
Prior art keywords
balloon
stent
mounting region
diameter
inflation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/894,946
Inventor
Lixiao Wang
John Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US10/894,946 priority Critical patent/US20050049671A1/en
Publication of US20050049671A1 publication Critical patent/US20050049671A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCIMED LIFE SYSTEMS, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • A61F2002/9583Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1059Balloon catheters with special features or adapted for special applications having different inflatable sections mainly depending on the response to the inflation pressure, e.g. due to different material properties

Definitions

  • the present invention relates generally to a method of installing a stent utilizing a balloon catheter to perform an initial angioplasty and to seat the stent after it has been located in the vessel.
  • the invention also relates to novel balloon structures which have particular use in the method of the invention. More specifically, this invention relates to a stent delivery system wherein at least a portion of the balloon is step compliant which provides the balloon with the ability to expand specific portions of the balloon at different times according to a variety of inflation pressures.
  • the unique shape of the balloon may be configured to engage the stent throughout the insertion as well as the delivery procedures which in turn reduces longitudinal movement of an associated medical device such as a stent, stent-graft, graft or vena cava filter mounted on the balloon both prior to and during balloon expansion.
  • an associated medical device such as a stent, stent-graft, graft or vena cava filter mounted on the balloon both prior to and during balloon expansion.
  • a stent is a generally cylindrical prosthesis introduced via a catheter into a lumen of a body vessel in a configuration having a generally reduced diameter and then expanded to the diameter of the vessel.
  • the stent may be self-expanding, such as a NITINOL shape memory stent, or it may be expandable by means of an inflatable portion of the catheter, such as a balloon. In its expanded configuration, the stent supports and reinforces the vessel walls while maintaining the vessel in an open, unobstructed condition.
  • Inflation expandable and inflation assisted expandable stents are well known and widely available in a variety of designs and configurations. Inflation expandable and inflation assisted expandable stents are expanded via outward radial pressure such as that provided by a balloon disposed underneath the stent during inflation of the balloon.
  • Medical device delivery balloons may have a variety of shapes, sizes, inflation characteristics and a variety of other performance attributes. Some examples of balloons which may be used for the expansion and delivery of a medical device are described in U.S. Pat. No. 5,556,383; U.S. Pat. No. 5,738,901; U.S. Pat. No. 6,024,752; and U.S. Pat. No. 6,048,350.
  • the stent In advancing an inflation expandable stent through a body vessel to the deployment site, there are a number of important considerations.
  • the stent must be able to securely maintain its axial position on the delivery catheter, without translocating proximally or distally, and especially without becoming separated from the catheter.
  • it may be desirable to protect the distal and proximal ends of the stent to prevent distortion of the stent and to prevent abrasion and/or to reduce potential trauma to the vessel walls.
  • a retractable sheath or sheaths which are disposed about the distal end of the catheter and cover the stent and balloon.
  • the sheath is retracted prior to the inflation of the balloon and subsequent delivery of the stent.
  • Another solution involves the utilization of one or more stent retaining means such as elastomeric sleeves or socks.
  • the socks are disposed about the ends of the stent and the respective adjacent portions of the catheter shaft. Socks may be constructed such that during balloon inflation the socks release the stent as a result of the forces and change in geometry resulting from the expanding balloon. It is also known that socks may be constructed to retract or be pulled off of the stent as a result of their construction and the expansion of the balloon.
  • Inflation expandable stent delivery and deployment assemblies are known which utilize restraining means that overlie the stent during delivery.
  • U.S. Pat. No. 4,950,227 to Savin et al. relates to an inflation expandable stent delivery system in which a sleeve overlaps the distal or proximal margin (or both) of the stent during delivery. During inflation of the stent at the deployment site, the stent margins are freed of the protective sleeve(s).
  • U.S. Pat. No. 5,403,341 to Solar relates to a stent delivery and deployment assembly which uses retaining sheaths positioned about opposite ends of the compressed stent.
  • the retaining sheaths of Solar are adapted to tear under pressure as the stent is radially expanded, thus releasing the stent from engagement with the sheaths.
  • U.S. Pat. No. 5,108,416 to Ryan et al. describes a stent introducer system which uses one or two flexible end caps and an annular socket surrounding the balloon to position the stent during introduction to the deployment site. The content of all references, including patents and patent applications are respectively incorporated it their entirety herein by reference.
  • Angioplasty an accepted and well known medical practice involves inserting a balloon catheter into the blood vessel of a patient, maneuvering and steering the catheter through the patient's vessels to the site of the lesion with the balloon in an uninflated form.
  • the uninflated balloon portion of the catheter is located within the blood vessel such that it crosses the lesion or reduced area.
  • Pressurized inflation fluid is metered to the inflatable balloon through a lumen formed in the catheter to thus dilate the restricted area.
  • the inflation fluid is generally a liquid and is applied at relatively high pressures, usually in the area of six to twenty atmospheres. As the balloon is inflated it expands and forces open the previously closed area of the blood vessel.
  • Balloons used in angioplasty procedures such as this are generally fabricated by molding and have predetermined design dimensions such as length, wall thickness and nominal diameter. Balloon catheters are also used in other systems of the body for example the prostate and the urethra. Balloon catheters come in a large range of sizes and must be suitably dimensioned for their intended use.
  • a typical procedure for stent installation involves performing an initial angioplasty to open the vessel to a predetermined diameter sufficient to permit passage of a stent delivery catheter across the lesion, removal of the angioplasty balloon catheter, insertion of a delivery catheter carrying the stent and a stent deploying mechanism, deploying the stent across the opened lesion so as to separate the stent from the catheter and bring it into contact with the vessel wall, usually with dilation to a lager diameter using a balloon larger than the balloon of the predilation catheter, and then removing the delivery catheter (after deflating the balloon if used).
  • stent configurations include various forms of bent wire devices, self-expanding stents; stents which unroll from a wrapped configuration on the catheter; and stents which are made of a deformable material so that the device may be deformed on deployment from a small diameter to a larger diameter configuration.
  • References disclosing stent devices and deployment catheters include: U.S. Pat. No. 4733665 Palmaz U.S. Pat. No. 4776337 Palmaz U.S. Pat. No. 5195984 Schatz U.S. Pat. No. 5234457 Andersen U.S. Pat. No. 5116360 Pinchuck et al U.S.
  • a single layer balloon which follows a stepped compliance curve.
  • the stepped compliance curves of these balloons has a lower pressure segment following a first generally linear profile, a transition region, typically in the 8-14 atm range, during which the balloon rapidly expands yielding in elastically, and a higher pressure region in which the balloon expands along a generally linear, low compliance curve.
  • the stepped compliance curve allows a physician to dilate different sized lesions without using multiple balloon catheters.
  • Stepped compliance curve catheter balloon devices using two different coextensively mounted balloon portions of different initial inflated diameter are also described in U.S. Pat. No. 5,447,497 and in U.S. Pat. No. 5,358,487 to Miller. These dual layer balloons are designed with the outer balloon portion larger than the inner portion so that the compliance curve follows the inner balloon portion until it reaches burst diameter and then, after the inner balloon bursts, the outer balloon becomes inflated and can be expanded to a larger diameter than the burst diameter of the inner balloon.
  • a polyethylene ionomer balloon with a stepped compliance curve is disclosed in EP 540 858.
  • the reference suggests that the balloon can be used on stent delivery catheters.
  • the disclosed balloon material of this reference yields a compliant balloon and therefore a stent delivered with such a balloon would typically require “retouch.”
  • Balloons having a stepped compliance curve have also been described for use in stent delivery. Two examples of such stent delivery balloons and methods of their use are described in U.S. Pat. No. 5,749,851 and U.S. Pat. No. 5,980,532, respectively incorporated in their entirety herein by reference.
  • the invention in one aspect is directed to a medical balloon. More specifically, the present invention is directed to a stent delivery system employing a unique stepped compliant balloon which is shaped to retain a stent about a stent mounting region of the balloon prior to and during stent delivery.
  • the balloon is capable of providing low pressure predilation at a relatively small diameter to open the lesion sufficiently to allow insertion and deployment of the stent across the lesion and for subsequent high pressure embedding of the stent in the vessel wall.
  • the same balloon catheter may also be employed to insert and deploy the stent. Thus at least one catheter may be eliminated from what may otherwise be a two or three catheter installation process.
  • the balloon of the invention may be made by molding a balloon into a configuration in which the second portion has a larger diameter than the first portion and then shrinking the second portion to the diameter of the first portion or less than the diameter of the first portion.
  • the method of making such balloons comprises yet another aspect of the invention.
  • the balloon may be incorporated into a stent delivery catheter, wherein a stent mounting region of the balloon has a diameter less than the diameter of the balloon ends, whereby the stent is prevented from longitudinal migration relative to the catheter as a result of interference provided by the balloon ends.
  • the balloon may be configured to expand so that the stent remains held in place during balloon expansion.
  • the balloon is configured to have a first inflation state, a second inflation state, and a third or fully inflated state.
  • the balloon may be configured to expand such that the balloon ends maintain a larger diameter than the stent mounting region until a predetermined inflation pressure is achieved, whereupon the stent mounting region may expand to a diameter greater than the diameter of the balloon ends.
  • a stent delivery catheter may employ a stepped compliant balloon and one or more stent retaining sleeves.
  • the balloon may be configured such that the balloon ends inflate sufficiently to cause the sleeves to retract, whereupon the stent mounting region expands to release the stent.
  • FIG. 1 is a side view of an embodiment of the invention as depicted within a body vessel;
  • FIG. 2 is a side view of an embodiment of the invention wherein the balloon is depicted in a first inflation state
  • FIG. 3 is a side view of the embodiment of the invention shown in FIG. 2 , wherein the balloon is depicted in the second inflation state;
  • FIG. 4 is a side view of an alternative embodiment of the invention, wherein the balloon is depicted in the second inflation state;
  • FIG. 5 is a side view of an embodiment of the invention wherein the balloon is shown in the third inflation state
  • FIG. 6 is a side view of an embodiment of the invention which includes a pair of retractable stent retaining sleeves
  • FIG. 7 is a side view of the embodiment of the invention shown in FIG. 6 wherein the balloon is in the second inflation state and the sleeves are retracted;
  • FIG. 8 is a side view of an embodiment of the invention which includes a single retractable stent retaining sleeve;
  • FIG. 9 is a side view of the balloon shown in FIG. 8 shown in the first inflation state
  • FIG. 10 is a side view of the balloon shown in FIG. 9 shown in the second inflation state
  • FIG. 11 is a side view of the balloon shown in FIG. 10 shown in the third inflation state
  • FIG. 12 is a side view of an embodiment of the balloon shown in the first inflation state
  • FIG. 13 is a side view of the balloon shown in FIG. 12 shown in the second inflation state.
  • FIG. 14 is a side view of the balloon shown in FIG. 13 shown in the third inflation state.
  • the catheters employed in the practice of the present invention are most conveniently constructed as over-the-wire balloon catheters of conventional form for use in angioplasty, except that the balloon has a stepped compliance curve.
  • the present invention can be applied, in addition to over-the-wire catheters, to fixed-wire catheters, to shortened guide wire lumens or single operator exchange catheters, and to non over-the-wire balloon catheters.
  • this invention can be used with balloon catheters intended for use in any and all vascular systems of cavities of the body.
  • the present invention is directed to a stent delivery catheter, indicated generally at 10 , which employs a balloon 12 which is mounted to a distal portion 20 of the catheter shaft 28 .
  • the balloon 12 includes a stent mounting region 14 and a pair of adjacent end portions 16 .
  • a stent 18 is disposed about the stent mounting region 14 prior to stent delivery.
  • the stent 18 is delivered by advancing the distal portion 20 of the catheter 10 through a body lumen or vessel 22 to a legion site 24 .
  • the balloon 12 is then inflated to predetermined pressure to expand the stent to a fully expanded state.
  • the balloon 12 depicted in FIG. 1 is shown in what is referred to herein as the first inflation state.
  • the first inflation state is considered for purposes of this application to be an inflation state wherein the balloon 12 has been unfolded by an internal inflation pressure of about 1 to about 3 atmospheres.
  • the balloon 12 as shown in FIG. 1 is not yet expanded and is thus may be characterized as being unexpanded or nominally inflated.
  • the balloon 12 may be characterized as having at least two inflation states in addition to the first inflation state shown in FIG. 1 .
  • the balloon 12 is shown in the first inflation state; in FIGS. 3 and 6 , the balloon 12 is respectively shown in alternative second inflation states, and in FIG. 5 , the balloon 12 is shown in a third inflation state.
  • the catheter as a whole has a low profile sufficient for allowing the distal portion 20 of the catheter 10 to advance through a body lumen.
  • the stent mounting region 14 of the balloon 12 will typically have a diameter less than about 2.5 mm.
  • the diameter of the stent mounting region may also range from about 1.5 mm to about 2.5 mm.
  • the diameter of the end region(s) 16 will be greater than the diameter of the stent mounting region 14 .
  • the end region(s) 16 will typically be between about 1.65 mm to about 2.65 mm in diameter depending on the diameter of the stent mounting region 14 .
  • the balloon 12 is inflated by injecting a fluid or other inflation means into the balloon 12 .
  • the catheter 10 will be equipped with one or more inflation lumens (not shown) which are in fluid communication with the balloon and the proximal end of the catheter (not shown).
  • Lumens as well as inflation means for balloons, including the present catheter balloon are well known in the art.
  • the catheter 10 is equipped with marker bands 40 .
  • Marker bands may be used to denote the location of the stent on the catheter as well as to serve as a means of determining the location of the distal end of the catheter as it advances through the body.
  • the marker bands are typically constructed of radiopaque materials. Examples of suitable marker bands are described in U.S. application Ser. No. 09/327,234 entitled Radiopaque Bands and filed Jun. 7, 1999, the entire contents of which being incorporated herein by reference.
  • the balloon 12 will expand the stent 18 .
  • the balloon 12 has been inflated to a second inflation or inflated state.
  • the balloon 12 may be configured to provide the stent mounting region 14 and the end regions 16 with substantially the same diameter such as is shown.
  • the diameter of the stent mounting region 14 remains less than the diameter of the end regions 16 .
  • the diameter of the stent mounting region may range from about 3.0 to about 3.6 mm, in alternative embodiments however, the diameter may be less.
  • the balloon is configured to have end regions 16 which have diameters greater than the diameter of the stent mounting region 14 the diameter of the end portions will typically be about 0.1 mm to about 1 mm greater than the diameter of the stent mounting region 14 .
  • the end portions may be utilized to engage the ends 25 and 26 of the stent 18 thereby ensuring that the stent 18 does not migrate longitudinally relative to the balloon 12 .
  • the position of the stent 18 remains constant on the balloon 12 during insertion and advancement of the catheter 10 as well as during balloon inflation.
  • the balloon 12 may be further inflated to a third inflation state, such as is shown in FIG. 5 .
  • the balloon 12 may be at least partially stepped compliant.
  • the stent mounting region 14 is characterized as having a stepped compliance curve where as the adjacent end region(s) may be characterized as having a substantially linear compliance curve. Examples and description of a stepped compliant curves as well as a substantially linear compliance curve are described in U.S. Pat. No. 5,632,760 and U.S. Pat. No. 5,980,532, both of which are incorporated in their respective entireties herein by reference.
  • a stepped compliance curve may be characterized by a first or low pressure segment defined by a low inflation pressure range.
  • the low pressure segment of the stepped compliance curve of the stent mounting region 14 is generally collinear with a corresponding segment of the generally linear compliance curve of the end portions 16 which is defined by said low inflation pressure range.
  • the stepped compliance curve of the stent mounting regions 16 may also include a transition segment during which the balloon expands rapidly relative to the at least one adjacent region and a high pressure segment during which the compliance curve of the stent mounting region expands slowly relative to the transition segment.
  • the balloon 12 is inflated with pressure from about 12 to about 16 atmospheres.
  • the greater pressure of the third inflation state corresponds to the high pressure segment of the compliance cure.
  • the balloon 12 is constructed such that when the balloon 12 is inflated to the third inflation state, only the diameter of the stent mounting region 14 will continue to expand according to the high pressure segment of the stepped compliance curve.
  • the diameter of the end regions 16 will exhibit only nominal expansion if at all when the balloon 12 is inflated to the third inflation state.
  • the balloon 12 may be characterized as having a stent mounting region 14 which has a higher rate of expansion than the rate of expansion of the end regions 16 .
  • a stent mounting region 14 which has a higher rate of expansion than the rate of expansion of the end regions 16 .
  • the stent mounting region 14 will inflate to a greater degree than the end portions 16 .
  • Numerous methods could be applied to the balloon of the present invention to achieve different inflation rates.
  • the end regions 16 could incorporate a relatively hard coating and/or additional materials such as the relatively stiff high pressure polymeric materials, such as thermoplastic polymers and thermoset polymeric materials, poly(ethylene terephthalate) (commonly referred to as PET), polyimide, thermoplastic polyimide, polyamides, polyesters, polycarbonates, polyphenylene sulfides, polypropylene and rigid polyurethanes.
  • a relatively hard coating and/or additional materials such as the relatively stiff high pressure polymeric materials, such as thermoplastic polymers and thermoset polymeric materials, poly(ethylene terephthalate) (commonly referred to as PET), polyimide, thermoplastic polyimide, polyamides, polyesters, polycarbonates, polyphenylene sulfides, polypropylene and rigid polyurethanes.
  • PET poly(ethylene terephthalate)
  • polyimide thermoplastic polyimide
  • polyamides polyamides
  • polyesters polycarbonates
  • polyphenylene sulfides polypropylene and rigid
  • the catheter 10 may be equipped with retractable stent retaining sleeves 30 and 32 .
  • Each of the sleeves 30 and 32 have three portions: a catheter engagement portion 34 , an balloon end region overlaying portion 36 , and a stent end overlaying portion 38 .
  • the catheter engagement portion 34 is engaged to a portion of the catheter shaft 28 adjacent to the balloon 12 .
  • the sleeves 30 and 32 may be engaged to the catheter in any manner known. For example the sleeves may be frictionally engaged, adhesively bonded, chemically or heat welded or other wise attached to the catheter shaft 28 .
  • the end overlaying portion 36 of each sleeve is slidingly disposed about the end region 16 of the balloon 12 .
  • the stent end overlaying region 38 of each sleeve 30 and 32 extends on to the stent mounting region 14 of the balloon 12 and respectively overlays stent ends 25 and 26 .
  • the stent end overlaying region 38 of each sleeve 30 and 32 retains the stent 18 on the stent mounting region 14 of the balloon 12 prior to stent delivery.
  • the balloon 12 may be inflated to the third inflation state as is shown in FIG. 5 .
  • the sleeves 30 and 32 may be configured to retract off of the stent ends 25 and 26 when the balloon 12 is in the third inflation state rather than the second inflation state.
  • the catheter 10 may include a single sleeve 30 such as may be seen in FIG. 8 .
  • the invention may be directed exclusively to the inventive balloon 12 such as balloon 12 shown in FIG. 1 .
  • the balloon 12 is shown with a stent mounting region 14 distally adjacent to a single end portion 16 , such as may also be seen in FIG. 8 .
  • the balloon 12 is shown respectively in the first inflation state, the second inflation state and the third inflation state.
  • the balloon 12 may be incorporated into a balloon catheter or a stent delivery catheter such as those previously shown and described above, or as may be known in the art.
  • FIGS. 12-14 are directed to the balloon 12 portion of the catheter such as is shown in FIGS. 2-4 above.
  • the balloon 12 has a distal adjacent end 16 and a proximal adjacent end 17 which surround the stent mounting region 14 .
  • the embodiments shown in FIGS. 12-14 may be incorporated into any type of balloon catheter or stent delivery catheter especially those described herein.
  • the balloon 12 of FIGS. 9-14 may include the same inflation characteristics as the balloons 12 of the various embodiments of the invention previously described.
  • the stent may be deployed from the second inflation state by simply collapsing the balloon subsequent to achieving the second inflation state, such as is depicted in FIGS. 3, 4 and 7 .
  • the stent may be further expanded by inflating the balloon 12 to the third inflation state.
  • the balloon 12 may be used to predilate a vessel by expanding to the second inflation state, and then seating the stent in place by expanding the balloon 12 to the third inflation state such as is shown in FIG. 5 .
  • the balloon 12 of the various embodiments discussed herein should be made of a thermoplastic polymer material which has a high strength, and gives a low compliance balloon at pressures above about 15 atmospheres.
  • “low compliance” is considered to correspond to a diameter increase of no more than 0.1 mm per increased atmosphere of pressure, preferably less than 0.06 mm/atm.
  • the balloon polymer is poly(ethylene terephthalate) (PET) of initial intrinsic viscosity of at least 0.5, more preferably 0.7-0.9.
  • PEN poly(ethylene napthalenedicarboxylate)
  • nylons such as nylon 11 or nylon 12
  • thermoplastic polyimides and high strength engineering thermoplastic polyurethanes such as Isoplast 301 sold by Dow Chemical Co.
  • PebaxTM a block copolymer polyamide and polyether made by Elf Atochem.
  • the balloon is blown in a way which will give a wall strength of at least 18,000 psi, preferably greater than 20,000 psi. Techniques for manufacturing balloons with such wall strengths are well known.
  • the stent mounting region 14 of the balloon 12 is provided with a stepped compliance curve by annealing the balloon for a short time after blowing at a pressure at or only slightly above ambient and at a temperature which causes the blown balloon to shrink.
  • the process is described in U.S. Pat. No. 5,348,538, incorporated in its entirety herein by reference.
  • the balloons of the invention are desirably constructed with a greater difference between the low pressure and high pressure linear regions of the compliance curve so that the transition between the two regions results in a step-up of diameter of the balloon of at least 0.4 mm. This is accomplished by blowing the balloon to the larger diameter and then shrinking to a greater extent than was done in the specific illustrative examples of U.S. Pat.
  • the amount of shrinkage is controlled by the pressure maintained in the balloon during annealing and the temperature and time of the annealing.
  • the blowing pressure is suitably in the range 200-400 psi
  • temperature is suitably in the range of 90-100° C.
  • the annealing pressure is in the range of 0-20, preferably 5-10 psi at 90-100° for 3-10 seconds.
  • the balloons employed in the inventive process are configured so that the stent mounting region 14 of the balloon 12 has a stepped compliance curve and the remainder of the balloon, specifically the end region(s) 16 have an unstepped or substantially linear compliance curve, the low pressure regions of the compliance curves of both the stent mounting region 14 and the end region(s) 16 being generally collinear.
  • the invention may also be practices by use of dual layer balloons such as described in co-pending U.S. application Ser. No. 08/243,473, filed May 16, 1994 as a continuation of now abandoned U.S. application Ser. No. 07/927,062, filed Aug. 8, 1992, incorporated herein by reference, and in U.S. Pat. No. 5,358,487, incorporated herein by reference.
  • both balloons of the dual layer balloons are low compliance balloons designed with the outer balloon portion larger by at least 0.25 mm than the inner portion and the inner balloon designed to burst at a pressure below about 15 atm so that the compliance curve follows the inner balloon portion until it reaches burst diameter and then, after the inner balloon bursts, the outer balloon becomes inflated and can be expanded to a larger diameter than the burst diameter of the inner balloon.

Abstract

A stent delivery catheter comprising a catheter shaft and balloon engaged thereto. The balloon being inflatable from a first inflation state to a first expanded state as well as to a second expanded state. The balloon having a stent mounting region for retaining and delivery of a stent therefrom, and at least one adjacent region. The stent mounting region having a first diameter and the at least one adjacent region having a second diameter. In the first inflation state the first diameter being less than the second diameter. In the first expanded state the first diameter being no greater than the second diameter. In the second expanded state the first diameter being greater than the second diameter. The stent being retained on the stent mounting region by engagement of the at least one adjacent portion and at least one retractable stent retaining sleeve.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • Not Applicable
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
  • Not Applicable
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates generally to a method of installing a stent utilizing a balloon catheter to perform an initial angioplasty and to seat the stent after it has been located in the vessel. The invention also relates to novel balloon structures which have particular use in the method of the invention. More specifically, this invention relates to a stent delivery system wherein at least a portion of the balloon is step compliant which provides the balloon with the ability to expand specific portions of the balloon at different times according to a variety of inflation pressures. In addition the unique shape of the balloon may be configured to engage the stent throughout the insertion as well as the delivery procedures which in turn reduces longitudinal movement of an associated medical device such as a stent, stent-graft, graft or vena cava filter mounted on the balloon both prior to and during balloon expansion.
  • 2. Description of the Related Art
  • Expandable, implantable medical devices such as stents are utilized in a number of medical procedures and situations as are stent delivery assemblies. As such, their structure and function are well known. A stent is a generally cylindrical prosthesis introduced via a catheter into a lumen of a body vessel in a configuration having a generally reduced diameter and then expanded to the diameter of the vessel. The stent may be self-expanding, such as a NITINOL shape memory stent, or it may be expandable by means of an inflatable portion of the catheter, such as a balloon. In its expanded configuration, the stent supports and reinforces the vessel walls while maintaining the vessel in an open, unobstructed condition.
  • Self-expanding, inflation assisted expandable and inflation expandable stents are well known and widely available in a variety of designs and configurations. Inflation expandable and inflation assisted expandable stents are expanded via outward radial pressure such as that provided by a balloon disposed underneath the stent during inflation of the balloon.
  • Medical device delivery balloons may have a variety of shapes, sizes, inflation characteristics and a variety of other performance attributes. Some examples of balloons which may be used for the expansion and delivery of a medical device are described in U.S. Pat. No. 5,556,383; U.S. Pat. No. 5,738,901; U.S. Pat. No. 6,024,752; and U.S. Pat. No. 6,048,350.
  • In advancing an inflation expandable stent through a body vessel to the deployment site, there are a number of important considerations. The stent must be able to securely maintain its axial position on the delivery catheter, without translocating proximally or distally, and especially without becoming separated from the catheter. Furthermore, it may be desirable to protect the distal and proximal ends of the stent to prevent distortion of the stent and to prevent abrasion and/or to reduce potential trauma to the vessel walls.
  • To address the concerns stated above, one approach has been identified which utilizes a retractable sheath or sheaths which are disposed about the distal end of the catheter and cover the stent and balloon. In such devices the sheath is retracted prior to the inflation of the balloon and subsequent delivery of the stent. Another solution involves the utilization of one or more stent retaining means such as elastomeric sleeves or socks. The socks are disposed about the ends of the stent and the respective adjacent portions of the catheter shaft. Socks may be constructed such that during balloon inflation the socks release the stent as a result of the forces and change in geometry resulting from the expanding balloon. It is also known that socks may be constructed to retract or be pulled off of the stent as a result of their construction and the expansion of the balloon.
  • Inflation expandable stent delivery and deployment assemblies are known which utilize restraining means that overlie the stent during delivery. U.S. Pat. No. 4,950,227 to Savin et al., relates to an inflation expandable stent delivery system in which a sleeve overlaps the distal or proximal margin (or both) of the stent during delivery. During inflation of the stent at the deployment site, the stent margins are freed of the protective sleeve(s). U.S. Pat. No. 5,403,341 to Solar, relates to a stent delivery and deployment assembly which uses retaining sheaths positioned about opposite ends of the compressed stent. The retaining sheaths of Solar are adapted to tear under pressure as the stent is radially expanded, thus releasing the stent from engagement with the sheaths. U.S. Pat. No. 5,108,416 to Ryan et al., describes a stent introducer system which uses one or two flexible end caps and an annular socket surrounding the balloon to position the stent during introduction to the deployment site. The content of all references, including patents and patent applications are respectively incorporated it their entirety herein by reference.
  • Providing a means for containing and securing the stent or other medical device on the balloon catheter prior to inflation is but one problem facing stent delivery systems. An additional concern is the shifting or sliding of the stent relative to the balloon during balloon expansion. Numerous attempts have been made to reduce or prevent translocation of the stent on the balloon during balloon expansion. For example: copending U.S. patent application Ser. No. 09/667,916, filed Sep. 22, 2000 and entitled Coated Stents with Better Gripping Ability, describes a stent coating which provides the stent with improved ability to adhere to the balloon during the expansion process. Another example is U.S. Pat. No. 5,836,965 which describes a process wherein a balloon is expanded and heat set then allowed to cool in order to adhere the balloon to the stent. Yet another example is co-pending U.S. patent application Ser. No. 08/740,727, filed Nov. 1, 1996 and entitled Selective Coating Of A Balloon Catheter With Lubricous Material For Stent Deployment, which describes a balloon having a tacky coating for securing a stent to a balloon prior to delivery.
  • Angioplasty, an accepted and well known medical practice involves inserting a balloon catheter into the blood vessel of a patient, maneuvering and steering the catheter through the patient's vessels to the site of the lesion with the balloon in an uninflated form. The uninflated balloon portion of the catheter is located within the blood vessel such that it crosses the lesion or reduced area. Pressurized inflation fluid is metered to the inflatable balloon through a lumen formed in the catheter to thus dilate the restricted area. The inflation fluid is generally a liquid and is applied at relatively high pressures, usually in the area of six to twenty atmospheres. As the balloon is inflated it expands and forces open the previously closed area of the blood vessel. Balloons used in angioplasty procedures such as this are generally fabricated by molding and have predetermined design dimensions such as length, wall thickness and nominal diameter. Balloon catheters are also used in other systems of the body for example the prostate and the urethra. Balloon catheters come in a large range of sizes and must be suitably dimensioned for their intended use.
  • Recently the use of a catheter delivered stent to prevent an opened lesion from reclosing or to reinforce a weakened vessel segment, such as an aneurism, has become a common procedure. A typical procedure for stent installation involves performing an initial angioplasty to open the vessel to a predetermined diameter sufficient to permit passage of a stent delivery catheter across the lesion, removal of the angioplasty balloon catheter, insertion of a delivery catheter carrying the stent and a stent deploying mechanism, deploying the stent across the opened lesion so as to separate the stent from the catheter and bring it into contact with the vessel wall, usually with dilation to a lager diameter using a balloon larger than the balloon of the predilation catheter, and then removing the delivery catheter (after deflating the balloon if used). In many cases it has become the practice to then “retouch” the dilation by deploying a third catheter carrying a balloon capable of dilating at a substantially higher pressure to drive the stent into the vessel wall, thereby to assure that there is no risk of the stent later shifting its position and to reduce occurrence of restenosis or thrombus formation. This third “retouch” dilation is often considered necessary when the balloon used to seat the stent is made of a compliant material because such balloons generally cannot be safely pressurized above 9-12 atm., and higher pressures are generally considered necessary to assure full uniform lesion dilation and seating of the stent.
  • A wide variety of stent configurations and deployment methods are known. For instance, stent configurations include various forms of bent wire devices, self-expanding stents; stents which unroll from a wrapped configuration on the catheter; and stents which are made of a deformable material so that the device may be deformed on deployment from a small diameter to a larger diameter configuration. References disclosing stent devices and deployment catheters include:
    U.S. Pat. No. 4733665 Palmaz
    U.S. Pat. No. 4776337 Palmaz
    U.S. Pat. No. 5195984 Schatz
    U.S. Pat. No. 5234457 Andersen
    U.S. Pat. No. 5116360 Pinchuck et al
    U.S. Pat. No. 5116318 Hillstead
    U.S. Pat. No. 4649922 Wiktor
    U.S. Pat. No. 4655771 Wallsten
    U.S. Pat. No. 5089006 Stiles
    U.S. Pat. No. 5007926 Derbyshire
    U.S. Pat. No. 4705517 DiPisa, Jr.
    U.S. Pat. No. 4740207 Kreamer
    U.S. Pat. No. 4877030 Beck et al
    U.S. Pat. No. 5108417 Sawyer
    U.S. Pat. No. 4923464 DiPisa, Jr
    U.S. Pat. No. 5078726 Kreamer
    U.S. Pat. No. 5171262 MacGregor
    U.S. Pat. No. 5059211 Stack et al
    U.S. Pat. No. 5104399 Lazarus
    U.S. Pat. No. 5104404 Wolff
    U.S. Pat. No. 5019090 Pinchuk
    U.S. Pat. No. 4954126 Wallsten
    U.S. Pat. No. 4994071 MacGregor
    U.S. Pat. No. 4580568 Gianturco
    U.S. Pat. No. 4681110 Wiktor
    U.S. Pat. No. 4800882 Gianturco
    U.S. Pat. No. 4830003 Wolff et al
    U.S. Pat. No. 4856516 Hillstead
    U.S. Pat. No. 4922905 Strecker
    U.S. Pat. No. 4886062 Wiktor
    U.S. Pat. No. 4907336 Gianturco
    U.S. Pat. No. 4913141 Hillstead
    U.S. Pat. No. 5092877 Pinchuk
    U.S. Pat. No. 5123917 Lee
    U.S. Pat. No. 5116309 Coll
    U.S. Pat. No. 5122154 Rhodes
    U.S. Pat. No. 5133732 Wiktor
    U.S. Pat. No. 5135536 Hillstead
    U.S. Pat. No. 5282824 Gianturco
    U.S. Pat. No. 5292331 Boneau
    U.S. Pat. No. 5035706 Gianturco et al
    U.S. Pat. No. 5041126 Gianturco
    U.S. Pat. No. 5061275 Wallsten et al
    U.S. Pat. No. 5064435 Porter
    U.S. Pat. No. 5092841 Spears
    U.S. Pat. No. 5108416 Ryan et al
    U.S. Pat. No. 4990151 Wallsten
    U.S. Pat. No. 4990155 Wilkoff
    U.S. Pat. No. 4969890 Sugita et al
    U.S. Pat. No. 4795458 Regan
    U.S. Pat. No. 4760849 Kropf
    U.S. Pat. No. 5192297 Hull
    U.S. Pat. No. 5147385 Beck et al
    U.S. Pat. No. 5163952 Froix
  • In U.S. Pat. No. 5,348,538, the entire contents of which being incorporated herein by reference, there is described a single layer balloon which follows a stepped compliance curve. The stepped compliance curves of these balloons has a lower pressure segment following a first generally linear profile, a transition region, typically in the 8-14 atm range, during which the balloon rapidly expands yielding in elastically, and a higher pressure region in which the balloon expands along a generally linear, low compliance curve. The stepped compliance curve allows a physician to dilate different sized lesions without using multiple balloon catheters.
  • Stepped compliance curve catheter balloon devices using two different coextensively mounted balloon portions of different initial inflated diameter, are also described in U.S. Pat. No. 5,447,497 and in U.S. Pat. No. 5,358,487 to Miller. These dual layer balloons are designed with the outer balloon portion larger than the inner portion so that the compliance curve follows the inner balloon portion until it reaches burst diameter and then, after the inner balloon bursts, the outer balloon becomes inflated and can be expanded to a larger diameter than the burst diameter of the inner balloon.
  • A polyethylene ionomer balloon with a stepped compliance curve is disclosed in EP 540 858. The reference suggests that the balloon can be used on stent delivery catheters. The disclosed balloon material of this reference, however, yields a compliant balloon and therefore a stent delivered with such a balloon would typically require “retouch.”
  • Balloons having a stepped compliance curve have also been described for use in stent delivery. Two examples of such stent delivery balloons and methods of their use are described in U.S. Pat. No. 5,749,851 and U.S. Pat. No. 5,980,532, respectively incorporated in their entirety herein by reference.
  • The entire content of all of the patents and patent applications listed within the present patent application are respectively incorporated in their entirety herein by reference.
  • BRIEF SUMMARY OF THE INVENTION
  • The invention in one aspect is directed to a medical balloon. More specifically, the present invention is directed to a stent delivery system employing a unique stepped compliant balloon which is shaped to retain a stent about a stent mounting region of the balloon prior to and during stent delivery. The balloon is capable of providing low pressure predilation at a relatively small diameter to open the lesion sufficiently to allow insertion and deployment of the stent across the lesion and for subsequent high pressure embedding of the stent in the vessel wall. The same balloon catheter may also be employed to insert and deploy the stent. Thus at least one catheter may be eliminated from what may otherwise be a two or three catheter installation process.
  • In at least one embodiment of the invention, the balloon of the invention may be made by molding a balloon into a configuration in which the second portion has a larger diameter than the first portion and then shrinking the second portion to the diameter of the first portion or less than the diameter of the first portion. The method of making such balloons comprises yet another aspect of the invention.
  • In at least one embodiment of the invention the, the balloon may be incorporated into a stent delivery catheter, wherein a stent mounting region of the balloon has a diameter less than the diameter of the balloon ends, whereby the stent is prevented from longitudinal migration relative to the catheter as a result of interference provided by the balloon ends. The balloon may be configured to expand so that the stent remains held in place during balloon expansion.
  • In at least one embodiment of the invention the balloon is configured to have a first inflation state, a second inflation state, and a third or fully inflated state.
  • In yet another embodiment of the invention the balloon may be configured to expand such that the balloon ends maintain a larger diameter than the stent mounting region until a predetermined inflation pressure is achieved, whereupon the stent mounting region may expand to a diameter greater than the diameter of the balloon ends.
  • In yet another aspect of the invention a stent delivery catheter may employ a stepped compliant balloon and one or more stent retaining sleeves. The balloon may be configured such that the balloon ends inflate sufficiently to cause the sleeves to retract, whereupon the stent mounting region expands to release the stent.
  • These and other more detailed and specific objectives and an understanding of the invention will become apparent from a consideration of the following Detailed Description of the Invention in view of the Drawings. Other embodiments may also be apparent, but which are not described in detail, from the following description.
  • BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
  • A detailed description of the invention is hereafter described with specific reference being made to the drawings in which:
  • FIG. 1 is a side view of an embodiment of the invention as depicted within a body vessel;
  • FIG. 2 is a side view of an embodiment of the invention wherein the balloon is depicted in a first inflation state;
  • FIG. 3 is a side view of the embodiment of the invention shown in FIG. 2, wherein the balloon is depicted in the second inflation state;
  • FIG. 4 is a side view of an alternative embodiment of the invention, wherein the balloon is depicted in the second inflation state;
  • FIG. 5 is a side view of an embodiment of the invention wherein the balloon is shown in the third inflation state;
  • FIG. 6 is a side view of an embodiment of the invention which includes a pair of retractable stent retaining sleeves;
  • FIG. 7 is a side view of the embodiment of the invention shown in FIG. 6 wherein the balloon is in the second inflation state and the sleeves are retracted;
  • FIG. 8 is a side view of an embodiment of the invention which includes a single retractable stent retaining sleeve;
  • FIG. 9 is a side view of the balloon shown in FIG. 8 shown in the first inflation state;
  • FIG. 10 is a side view of the balloon shown in FIG. 9 shown in the second inflation state;
  • FIG. 11 is a side view of the balloon shown in FIG. 10 shown in the third inflation state;
  • FIG. 12 is a side view of an embodiment of the balloon shown in the first inflation state;
  • FIG. 13 is a side view of the balloon shown in FIG. 12 shown in the second inflation state; and
  • FIG. 14 is a side view of the balloon shown in FIG. 13 shown in the third inflation state.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The catheters employed in the practice of the present invention are most conveniently constructed as over-the-wire balloon catheters of conventional form for use in angioplasty, except that the balloon has a stepped compliance curve. However it should be understood that the present invention can be applied, in addition to over-the-wire catheters, to fixed-wire catheters, to shortened guide wire lumens or single operator exchange catheters, and to non over-the-wire balloon catheters. Furthermore this invention can be used with balloon catheters intended for use in any and all vascular systems of cavities of the body.
  • As may be seen in FIG. 1, the present invention is directed to a stent delivery catheter, indicated generally at 10, which employs a balloon 12 which is mounted to a distal portion 20 of the catheter shaft 28. In the present invention, the balloon 12 includes a stent mounting region 14 and a pair of adjacent end portions 16.
  • A stent 18 is disposed about the stent mounting region 14 prior to stent delivery. The stent 18 is delivered by advancing the distal portion 20 of the catheter 10 through a body lumen or vessel 22 to a legion site 24. The balloon 12 is then inflated to predetermined pressure to expand the stent to a fully expanded state.
  • As is know to those of skill in the art, when a medical balloon of catheter is in the non-inflated state, the balloon will typically include one or more folds. The folded configuration of the balloon provides numerous benefits to the catheter device. An example of a folded balloon is described in U.S. Pat. App. 09/335,361, filed Jun. 17, 1999 and entitled Stent Securement By Balloon Modification, the entire contents of which being incorporated herein by reference. The balloon 12 depicted in FIG. 1 is shown in what is referred to herein as the first inflation state. However, the first inflation state is considered for purposes of this application to be an inflation state wherein the balloon 12 has been unfolded by an internal inflation pressure of about 1 to about 3 atmospheres. Despite, being “unfolded” by such pressure, the balloon 12 as shown in FIG. 1 is not yet expanded and is thus may be characterized as being unexpanded or nominally inflated.
  • As may be seen in FIGS. 2-5 the balloon 12 may be characterized as having at least two inflation states in addition to the first inflation state shown in FIG. 1. In FIG. 2, the balloon 12 is shown in the first inflation state; in FIGS. 3 and 6, the balloon 12 is respectively shown in alternative second inflation states, and in FIG. 5, the balloon 12 is shown in a third inflation state.
  • As may be seen in FIG. 2, when the balloon 12 is in the first inflation state, the catheter as a whole has a low profile sufficient for allowing the distal portion 20 of the catheter 10 to advance through a body lumen. In the first inflation state the stent mounting region 14 of the balloon 12 will typically have a diameter less than about 2.5 mm. The diameter of the stent mounting region may also range from about 1.5 mm to about 2.5 mm. In the first inflation state, the diameter of the end region(s) 16 will be greater than the diameter of the stent mounting region 14. The end region(s) 16 will typically be between about 1.65 mm to about 2.65 mm in diameter depending on the diameter of the stent mounting region 14.
  • The balloon 12 is inflated by injecting a fluid or other inflation means into the balloon 12. Typically the catheter 10 will be equipped with one or more inflation lumens (not shown) which are in fluid communication with the balloon and the proximal end of the catheter (not shown). Lumens as well as inflation means for balloons, including the present catheter balloon are well known in the art.
  • It may also be seen that in the embodiment shown in FIG. 2, the catheter 10 is equipped with marker bands 40. Marker bands may be used to denote the location of the stent on the catheter as well as to serve as a means of determining the location of the distal end of the catheter as it advances through the body. The marker bands are typically constructed of radiopaque materials. Examples of suitable marker bands are described in U.S. application Ser. No. 09/327,234 entitled Radiopaque Bands and filed Jun. 7, 1999, the entire contents of which being incorporated herein by reference.
  • As the balloon 12 is inflated, the balloon 12 will expand the stent 18. As may be seen in FIG. 3, the balloon 12 has been inflated to a second inflation or inflated state. In the second inflation state the balloon 12 may be configured to provide the stent mounting region 14 and the end regions 16 with substantially the same diameter such as is shown. However, in the embodiment illustrated in FIG. 4, when the balloon 12 is in the second inflation state, the diameter of the stent mounting region 14 remains less than the diameter of the end regions 16. In the second inflation state the diameter of the stent mounting region may range from about 3.0 to about 3.6 mm, in alternative embodiments however, the diameter may be less. Where the balloon is configured to have end regions 16 which have diameters greater than the diameter of the stent mounting region 14 the diameter of the end portions will typically be about 0.1 mm to about 1 mm greater than the diameter of the stent mounting region 14.
  • By providing the balloon 12 with end regions 16 that have a greater diameter than that of the stent mounting region 14, the end portions may be utilized to engage the ends 25 and 26 of the stent 18 thereby ensuring that the stent 18 does not migrate longitudinally relative to the balloon 12. By providing such enlarged end regions in both the first inflation state, such as is shown in FIG. 2 as well as in the second inflation state, such as is shown in FIG. 4, the position of the stent 18 remains constant on the balloon 12 during insertion and advancement of the catheter 10 as well as during balloon inflation.
  • Subsequent to inflating the balloon 12 to a second inflation state, such as is shown in FIGS. 3 and 4, the balloon 12 may be further inflated to a third inflation state, such as is shown in FIG. 5.
  • As previously described the balloon 12 may be at least partially stepped compliant. In the embodiments discussed thus far the stent mounting region 14 is characterized as having a stepped compliance curve where as the adjacent end region(s) may be characterized as having a substantially linear compliance curve. Examples and description of a stepped compliant curves as well as a substantially linear compliance curve are described in U.S. Pat. No. 5,632,760 and U.S. Pat. No. 5,980,532, both of which are incorporated in their respective entireties herein by reference. Typically, a stepped compliance curve may be characterized by a first or low pressure segment defined by a low inflation pressure range. In the present invention, the low pressure segment of the stepped compliance curve of the stent mounting region 14 is generally collinear with a corresponding segment of the generally linear compliance curve of the end portions 16 which is defined by said low inflation pressure range. The stepped compliance curve of the stent mounting regions 16 may also include a transition segment during which the balloon expands rapidly relative to the at least one adjacent region and a high pressure segment during which the compliance curve of the stent mounting region expands slowly relative to the transition segment.
  • In the third inflation state the balloon 12 is inflated with pressure from about 12 to about 16 atmospheres. The greater pressure of the third inflation state corresponds to the high pressure segment of the compliance cure. The balloon 12 is constructed such that when the balloon 12 is inflated to the third inflation state, only the diameter of the stent mounting region 14 will continue to expand according to the high pressure segment of the stepped compliance curve. The diameter of the end regions 16 will exhibit only nominal expansion if at all when the balloon 12 is inflated to the third inflation state.
  • Alternatively, the balloon 12 may be characterized as having a stent mounting region 14 which has a higher rate of expansion than the rate of expansion of the end regions 16. Such that when the balloon 12 is inflated with a predetermined inflation pressure, the stent mounting region 14 will inflate to a greater degree than the end portions 16. Numerous methods could be applied to the balloon of the present invention to achieve different inflation rates. For example the end regions 16 could incorporate a relatively hard coating and/or additional materials such as the relatively stiff high pressure polymeric materials, such as thermoplastic polymers and thermoset polymeric materials, poly(ethylene terephthalate) (commonly referred to as PET), polyimide, thermoplastic polyimide, polyamides, polyesters, polycarbonates, polyphenylene sulfides, polypropylene and rigid polyurethanes. Such materials or coatings could be applied to a portion of the end region 16 to provide the region(s) 16 with a reduced rate of inflation relative to the stent mounting region 14. In addition, one or both expansion rates may also be characterized as being stepped compliant as described above.
  • In an alternative embodiment shown in FIG. 6, the catheter 10 may be equipped with retractable stent retaining sleeves 30 and 32. Each of the sleeves 30 and 32 have three portions: a catheter engagement portion 34, an balloon end region overlaying portion 36, and a stent end overlaying portion 38. The catheter engagement portion 34 is engaged to a portion of the catheter shaft 28 adjacent to the balloon 12. The sleeves 30 and 32 may be engaged to the catheter in any manner known. For example the sleeves may be frictionally engaged, adhesively bonded, chemically or heat welded or other wise attached to the catheter shaft 28. The end overlaying portion 36 of each sleeve is slidingly disposed about the end region 16 of the balloon 12. The stent end overlaying region 38 of each sleeve 30 and 32, extends on to the stent mounting region 14 of the balloon 12 and respectively overlays stent ends 25 and 26. The stent end overlaying region 38 of each sleeve 30 and 32 retains the stent 18 on the stent mounting region 14 of the balloon 12 prior to stent delivery.
  • As may be seen in FIG. 7, when the balloon 12 is inflated to the second inflation state, the sleeves 30 and 32 are retracted off of the respective stent ends 25 and 26 to release the stent.
  • In the embodiments shown in FIGS. 3, 4 and 7, the balloon 12 may be inflated to the third inflation state as is shown in FIG. 5. In addition the sleeves 30 and 32 may be configured to retract off of the stent ends 25 and 26 when the balloon 12 is in the third inflation state rather than the second inflation state.
  • Alternatively, the catheter 10 may include a single sleeve 30 such as may be seen in FIG. 8.
  • In another alternative embodiment of the invention may be seen in FIGS. 9-11, the invention may be directed exclusively to the inventive balloon 12 such as balloon 12 shown in FIG. 1. In the present embodiment, the balloon 12 is shown with a stent mounting region 14 distally adjacent to a single end portion 16, such as may also be seen in FIG. 8. In FIGS. 9-11 the balloon 12 is shown respectively in the first inflation state, the second inflation state and the third inflation state. The balloon 12 may be incorporated into a balloon catheter or a stent delivery catheter such as those previously shown and described above, or as may be known in the art.
  • Similar to the embodiments shown in FIGS. 9-11, the alternative embodiments shown in FIGS. 12-14 are directed to the balloon 12 portion of the catheter such as is shown in FIGS. 2-4 above. In the embodiments shown in FIGS. 12-14, the balloon 12 has a distal adjacent end 16 and a proximal adjacent end 17 which surround the stent mounting region 14. As with the previous embodiments, the embodiments shown in FIGS. 12-14 may be incorporated into any type of balloon catheter or stent delivery catheter especially those described herein. The balloon 12 of FIGS. 9-14 may include the same inflation characteristics as the balloons 12 of the various embodiments of the invention previously described.
  • In all of the embodiments described herein, if a stent is utilized with the balloon 12 the stent may be deployed from the second inflation state by simply collapsing the balloon subsequent to achieving the second inflation state, such as is depicted in FIGS. 3, 4 and 7. However, the stent may be further expanded by inflating the balloon 12 to the third inflation state. By further expanding the stent 18 in this manner the balloon 12 may be used to predilate a vessel by expanding to the second inflation state, and then seating the stent in place by expanding the balloon 12 to the third inflation state such as is shown in FIG. 5.
  • The balloon 12 of the various embodiments discussed herein should be made of a thermoplastic polymer material which has a high strength, and gives a low compliance balloon at pressures above about 15 atmospheres. For purposes of this application “low compliance” is considered to correspond to a diameter increase of no more than 0.1 mm per increased atmosphere of pressure, preferably less than 0.06 mm/atm. Suitably the balloon polymer is poly(ethylene terephthalate) (PET) of initial intrinsic viscosity of at least 0.5, more preferably 0.7-0.9. Other high strength polyester materials, such as poly(ethylene napthalenedicarboxylate) (PEN), nylons such as nylon 11 or nylon 12, thermoplastic polyimides and high strength engineering thermoplastic polyurethanes such as Isoplast 301 sold by Dow Chemical Co., and Pebax™ (a block copolymer polyamide and polyether) made by Elf Atochem. are considered suitable alternative materials. Desirably the balloon is blown in a way which will give a wall strength of at least 18,000 psi, preferably greater than 20,000 psi. Techniques for manufacturing balloons with such wall strengths are well known.
  • After being blown, the stent mounting region 14 of the balloon 12 is provided with a stepped compliance curve by annealing the balloon for a short time after blowing at a pressure at or only slightly above ambient and at a temperature which causes the blown balloon to shrink. The process is described in U.S. Pat. No. 5,348,538, incorporated in its entirety herein by reference. However, the balloons of the invention are desirably constructed with a greater difference between the low pressure and high pressure linear regions of the compliance curve so that the transition between the two regions results in a step-up of diameter of the balloon of at least 0.4 mm. This is accomplished by blowing the balloon to the larger diameter and then shrinking to a greater extent than was done in the specific illustrative examples of U.S. Pat. No. 5,348,538. The amount of shrinkage is controlled by the pressure maintained in the balloon during annealing and the temperature and time of the annealing. For a balloon made from 0.74 intrinsic viscosity PET, the blowing pressure is suitably in the range 200-400 psi, and temperature is suitably in the range of 90-100° C., and the annealing pressure is in the range of 0-20, preferably 5-10 psi at 90-100° for 3-10 seconds.
  • In a further aspect of the invention, the balloons employed in the inventive process are configured so that the stent mounting region 14 of the balloon 12 has a stepped compliance curve and the remainder of the balloon, specifically the end region(s) 16 have an unstepped or substantially linear compliance curve, the low pressure regions of the compliance curves of both the stent mounting region 14 and the end region(s) 16 being generally collinear.
  • The invention may also be practices by use of dual layer balloons such as described in co-pending U.S. application Ser. No. 08/243,473, filed May 16, 1994 as a continuation of now abandoned U.S. application Ser. No. 07/927,062, filed Aug. 8, 1992, incorporated herein by reference, and in U.S. Pat. No. 5,358,487, incorporated herein by reference. Suitably both balloons of the dual layer balloons are low compliance balloons designed with the outer balloon portion larger by at least 0.25 mm than the inner portion and the inner balloon designed to burst at a pressure below about 15 atm so that the compliance curve follows the inner balloon portion until it reaches burst diameter and then, after the inner balloon bursts, the outer balloon becomes inflated and can be expanded to a larger diameter than the burst diameter of the inner balloon.
  • Although the present invention has been described in terms of specific embodiments, it is anticipated that alterations and modifications thereof will no doubt be come apparent to those skilled in the art. It is therefore intended that the following claims be interpreted as covering all such alterations and modifications as fall within the true spirit and scope of the invention.
  • In addition to being directed to the embodiments described above and claimed below, the present invention is further directed to embodiments having different combinations of the features described above and claimed below. As such, the invention is also directed to other embodiments having any other possible combination of the dependent features claimed below.
  • The above examples and disclosure are intended to be illustrative and not exhaustive. These examples and description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.

Claims (16)

1-33. (Cancelled)
34. A medical balloon comprising:
a stent mounting region and a pair of adjacent end regions,
the balloon being inflatable from a first inflation state to a second inflation state, in the first inflation state the stent mounting region having a diameter less than that of the adjacent end regions,
the stent mounting region having a first rate of expansion and the at adjacent region having a second rate of expansion, the first rate of expansion being greater than the second rate of expansion, whereby when the balloon is inflated from the first inflation state to the second inflation state by a predetermined inflation pressure the diameter of the stent mounting region is at least as large as the diameter of the adjacent and regions.
35. The medical balloon of claim 34 wherein when the balloon is expanded from the first inflation state to the second inflation state the balloon is pressurized to a pressure sufficient to expand a stent mounted over the stent mounting region to a first stent expanded state.
36. The medical balloon of claim 34 wherein the stent mounting region has a stepped compliance curve and each of the end regions have a substantially linear compliance curve, the stepped compliance curve being characterized by a low pressure segment defined by a low inflation pressure range, said low pressure segment being generally collinear with a corresponding segment of the generally linear compliance curve of the end regions which is defined by said low inflation pressure range, a transition segment during which the balloon expands rapidly relative to the end regions and a high pressure segment during which the compliance curve of the stent mounting region expands slowly relative to the transition segment.
37. The medical balloon of claim 36 wherein when the balloon is inflated to the second inflation state the stent mounting region is expanded according to the transition segment of the stepped compliance curve.
38. The medical balloon of claim 36 wherein when the balloon is inflated to the second inflation state the stent mounting region is expanded according to the low pressure segment of the stepped compliance curve.
39. The medical balloon of claim 34 wherein the balloon further comprises a third inflation state, in the third inflation state the diameter of the stent mounting region is greater than the diameter of the at least one adjacent region.
40. The medical balloon of claim 39 wherein when the balloon is inflated to the third inflation state the stent mounting region is expanded according to a transition segment of the stepped compliance curve.
41. The medical balloon of claim 39 wherein when the balloon is inflated to the third inflation state the stent mounting region is expanded according to the high pressure segment of the stepped compliance curve.
42. The medical balloon of claim 34 wherein when the balloon is in the first inflation state the diameter of the stent mounting region is about 1.5 mm to about 2.5 mm.
43. The medical balloon of claim 34 wherein when the balloon is in the first inflation state the end regions have a diameter of about 1.65 mm to about 2.65 mm.
44. The medical balloon of claim 34 wherein when the balloon is in the second inflation state the end regions have a diameter of about 2.0 mm to about 3.75 mm.
45. The medical balloon of claim 34 wherein when the balloon is in the third inflation state the diameter of the stent mounting region is about 2.75 mm to about 4.25 mm and the end regions have a diameter of about 2.0 mm to 3.75 mm.
46. The medical balloon of claim 34 wherein the stent mounting region has a hardness value greater than that of the adjacent end regions.
47. The medical balloon of claim 34 further comprising a coating, the coating being positioned on at least a portion of the adjacent end regions of the balloon and not on the stent mounting region, the coating effective to restrict expansion of the end regions at the predetermined inflation pressure.
48. The medical balloon of claim 47 wherein the coating is selected from at least one member of the group consisting of: poly(ethylene terephthalate) (commonly referred to as PET), polyimide, thermoplastic polyimide, polyamides, polyesters, polycarbonates, polyphenylene sulfides, polypropylene and rigid polyurethanes.
US10/894,946 2001-01-04 2004-07-20 Combined shaped balloon and stent protector Abandoned US20050049671A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/894,946 US20050049671A1 (en) 2001-01-04 2004-07-20 Combined shaped balloon and stent protector

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/754,661 US6764504B2 (en) 2001-01-04 2001-01-04 Combined shaped balloon and stent protector
US10/894,946 US20050049671A1 (en) 2001-01-04 2004-07-20 Combined shaped balloon and stent protector

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/754,661 Division US6764504B2 (en) 2001-01-04 2001-01-04 Combined shaped balloon and stent protector

Publications (1)

Publication Number Publication Date
US20050049671A1 true US20050049671A1 (en) 2005-03-03

Family

ID=25035772

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/754,661 Expired - Lifetime US6764504B2 (en) 2001-01-04 2001-01-04 Combined shaped balloon and stent protector
US10/894,946 Abandoned US20050049671A1 (en) 2001-01-04 2004-07-20 Combined shaped balloon and stent protector

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/754,661 Expired - Lifetime US6764504B2 (en) 2001-01-04 2001-01-04 Combined shaped balloon and stent protector

Country Status (1)

Country Link
US (2) US6764504B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040093062A1 (en) * 2001-03-22 2004-05-13 Hendrik Glastra Assembly with therapeutic action
US20080086192A1 (en) * 2006-10-10 2008-04-10 Boston Scientific Scimed, Inc. Stent protector design
US20080125706A1 (en) * 2006-08-18 2008-05-29 Derek Sutermeister Electrically actuated annelid
US20090018634A1 (en) * 2007-07-10 2009-01-15 Boston Scientific Scimed, Inc. Dual taper stent protector
US20090254166A1 (en) * 2008-02-05 2009-10-08 Chou Tony M Interventional catheter system and methods
US20100280431A1 (en) * 2007-07-18 2010-11-04 Enrique Criado Methods and systems for establishing retrograde carotid arterial blood flow
US20110034986A1 (en) * 2007-07-18 2011-02-10 Chou Tony M Systems and methods for treating a carotid artery
WO2015146259A1 (en) * 2014-03-27 2015-10-01 テルモ株式会社 Balloon catheter and method for manufacturing balloon

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037318B2 (en) * 2000-12-18 2006-05-02 Boston Scientific Scimed, Inc. Catheter for controlled stent delivery
US6863683B2 (en) 2001-09-19 2005-03-08 Abbott Laboratoris Vascular Entities Limited Cold-molding process for loading a stent onto a stent delivery system
US6972024B1 (en) * 2001-12-21 2005-12-06 Advanced Cardiovascular Systems, Inc. Method of treating vulnerable plaque
US6866679B2 (en) 2002-03-12 2005-03-15 Ev3 Inc. Everting stent and stent delivery system
US7226472B2 (en) * 2002-10-15 2007-06-05 Boston Scientific Scimed, Inc. Catheter balloon with advantageous cone design
US6835189B2 (en) * 2002-10-15 2004-12-28 Scimed Life Systems, Inc. Controlled deployment balloon
US7367989B2 (en) * 2003-02-27 2008-05-06 Scimed Life Systems, Inc. Rotating balloon expandable sheath bifurcation delivery
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7731747B2 (en) 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US7972372B2 (en) 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US8318078B2 (en) * 2003-06-23 2012-11-27 Boston Scientific Scimed, Inc. Asymmetric stent delivery system with proximal edge protection and method of manufacture thereof
US8784472B2 (en) * 2003-08-15 2014-07-22 Boston Scientific Scimed, Inc. Clutch driven stent delivery system
US7686841B2 (en) 2003-12-29 2010-03-30 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery system
US7922753B2 (en) 2004-01-13 2011-04-12 Boston Scientific Scimed, Inc. Bifurcated stent delivery system
US8012192B2 (en) 2004-02-18 2011-09-06 Boston Scientific Scimed, Inc. Multi-stent delivery system
US7744619B2 (en) 2004-02-24 2010-06-29 Boston Scientific Scimed, Inc. Rotatable catheter assembly
US7922740B2 (en) 2004-02-24 2011-04-12 Boston Scientific Scimed, Inc. Rotatable catheter assembly
US7651525B2 (en) * 2004-08-05 2010-01-26 Medtronic Vascular, Inc. Intraluminal stent assembly and method of deploying the same
US7879053B2 (en) * 2004-12-20 2011-02-01 Boston Scientific Scimed, Inc. Balloon with stepped sections and implements
US20060135985A1 (en) * 2004-12-21 2006-06-22 Cox Daniel L Vulnerable plaque modification methods and apparatuses
US7862601B2 (en) * 2005-05-23 2011-01-04 Incept Llc Apparatus and methods for delivering a stent into an ostium
US7780723B2 (en) 2005-06-13 2010-08-24 Edwards Lifesciences Corporation Heart valve delivery system
US8790396B2 (en) * 2005-07-27 2014-07-29 Medtronic 3F Therapeutics, Inc. Methods and systems for cardiac valve delivery
JP2009538192A (en) * 2006-05-23 2009-11-05 プロビデンス ヘルス システム−オレゴン ディー/ビー/エー プロビデンス セント ビンセント メディカル センター System and method for introducing and applying a bandage structure within a body lumen or body hollow organ
US8333000B2 (en) 2006-06-19 2012-12-18 Advanced Cardiovascular Systems, Inc. Methods for improving stent retention on a balloon catheter
US20080021546A1 (en) * 2006-07-18 2008-01-24 Tim Patz System for deploying balloon-expandable heart valves
US8177829B2 (en) * 2006-08-23 2012-05-15 Boston Scientific Scimed, Inc. Auxiliary balloon catheter
US20080132988A1 (en) * 2006-12-01 2008-06-05 Scimed Life Systems, Inc. Balloon geometry for delivery and deployment of shape memory polymer stent with flares
US20080154352A1 (en) * 2006-12-21 2008-06-26 Medtronic Vascular, Inc. Stent Balloon Assembly and Method of Making Same
US20090018635A1 (en) * 2007-07-10 2009-01-15 Boston Scientific Scimed, Inc. Stent protector
US20090018633A1 (en) * 2007-07-10 2009-01-15 Boston Scientific Scimed, Inc. Protector for an insertable or implantable medical device
US9061119B2 (en) 2008-05-09 2015-06-23 Edwards Lifesciences Corporation Low profile delivery system for transcatheter heart valve
US8333003B2 (en) 2008-05-19 2012-12-18 Boston Scientific Scimed, Inc. Bifurcation stent crimping systems and methods
US8758422B2 (en) * 2008-06-11 2014-06-24 Boston Scientific Scimed, Inc. Edge protection via tapered balloon wrap
US20090312830A1 (en) * 2008-06-17 2009-12-17 Mcnulty Sean Balloon arc profile control
US8309007B2 (en) * 2008-08-01 2012-11-13 Boston Scientific Scimed, Inc. Folding apparatus and methods for bifurcation post-dilatation balloon
US8715331B2 (en) * 2008-08-06 2014-05-06 Boston Scientific Scimed, Inc. Stent edge protection and methods
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US8133199B2 (en) 2008-08-27 2012-03-13 Boston Scientific Scimed, Inc. Electroactive polymer activation system for a medical device
US8591567B2 (en) * 2008-11-25 2013-11-26 Edwards Lifesciences Corporation Apparatus and method for in situ expansion of prosthetic device
EP2196174B1 (en) * 2008-12-12 2014-02-26 Abbott Laboratories Vascular Enterprises Limited Process for loading a stent onto a stent delivery system
US8366763B2 (en) 2009-07-02 2013-02-05 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
US20110106234A1 (en) * 2009-10-30 2011-05-05 Axel Grandt Interluminal medical treatment devices and methods
WO2012071542A2 (en) 2010-11-24 2012-05-31 Tryton Medical, Inc. Support for treating vascular bifurcations
US9155619B2 (en) 2011-02-25 2015-10-13 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
US9339384B2 (en) * 2011-07-27 2016-05-17 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
AU2012347644B2 (en) * 2011-12-09 2017-04-20 Boston Scientific Scimed, Inc. Subintimal recanalization with bio-absorbable stent
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US20130226278A1 (en) * 2012-02-23 2013-08-29 Tyco Healthcare Group Lp Methods and apparatus for luminal stenting
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
WO2013162724A1 (en) 2012-04-26 2013-10-31 Tryton Medical, Inc. Support for treating vascular bifurcations
JP6026775B2 (en) * 2012-05-25 2016-11-16 株式会社グッドマン Stent delivery catheter
JP2014023911A (en) * 2012-06-20 2014-02-06 Kaneka Corp Balloon, balloon catheter, and method for producing balloon
US9724222B2 (en) 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
JP6483941B2 (en) * 2013-03-27 2019-03-13 株式会社カネカ Balloon, balloon catheter, and balloon manufacturing method
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US8968383B1 (en) 2013-08-27 2015-03-03 Covidien Lp Delivery of medical devices
GB2525005B (en) 2014-04-09 2016-03-09 Cook Medical Technologies Llc Delivery system for implantable medical device
DE102015112390A1 (en) 2015-07-29 2017-02-02 Bentley Innomed Gmbh balloon catheter
US10179046B2 (en) 2015-08-14 2019-01-15 Edwards Lifesciences Corporation Gripping and pushing device for medical instrument
US10314703B2 (en) * 2015-09-21 2019-06-11 Edwards Lifesciences Corporation Cylindrical implant and balloon
US11259920B2 (en) 2015-11-03 2022-03-01 Edwards Lifesciences Corporation Adapter for prosthesis delivery device and methods of use
US10321996B2 (en) 2015-11-11 2019-06-18 Edwards Lifesciences Corporation Prosthetic valve delivery apparatus having clutch mechanism
US10799677B2 (en) 2016-03-21 2020-10-13 Edwards Lifesciences Corporation Multi-direction steerable handles for steering catheters
US10799676B2 (en) 2016-03-21 2020-10-13 Edwards Lifesciences Corporation Multi-direction steerable handles for steering catheters
US11219746B2 (en) 2016-03-21 2022-01-11 Edwards Lifesciences Corporation Multi-direction steerable handles for steering catheters
US10433857B2 (en) * 2016-06-24 2019-10-08 Bryan Medical, Inc. Balloon dilation catheter
EP3528885B1 (en) 2016-10-18 2024-03-13 Boston Scientific Scimed Inc. Guide extension catheter
WO2018125806A1 (en) * 2016-12-29 2018-07-05 Boston Scientific Scimed, Inc. Hydration delivery system for stents
US10376396B2 (en) 2017-01-19 2019-08-13 Covidien Lp Coupling units for medical device delivery systems
LT3558169T (en) 2017-04-18 2022-02-10 Edwards Lifesciences Corporation Heart valve sealing devices and delivery devices therefor
US11224511B2 (en) 2017-04-18 2022-01-18 Edwards Lifesciences Corporation Heart valve sealing devices and delivery devices therefor
US10973634B2 (en) 2017-04-26 2021-04-13 Edwards Lifesciences Corporation Delivery apparatus for a prosthetic heart valve
US10959846B2 (en) 2017-05-10 2021-03-30 Edwards Lifesciences Corporation Mitral valve spacer device
CN110996853B (en) 2017-06-30 2023-01-10 爱德华兹生命科学公司 Docking station for transcatheter valve
CA3068311A1 (en) 2017-06-30 2019-01-03 Edwards Lifesciences Corporation Lock and release mechanisms for trans-catheter implantable devices
US10857334B2 (en) 2017-07-12 2020-12-08 Edwards Lifesciences Corporation Reduced operation force inflator
US10806573B2 (en) 2017-08-22 2020-10-20 Edwards Lifesciences Corporation Gear drive mechanism for heart valve delivery apparatus
US11051939B2 (en) 2017-08-31 2021-07-06 Edwards Lifesciences Corporation Active introducer sheath system
SG11202002918YA (en) 2017-10-18 2020-05-28 Edwards Lifesciences Corp Catheter assembly
US11207499B2 (en) 2017-10-20 2021-12-28 Edwards Lifesciences Corporation Steerable catheter
US11413176B2 (en) 2018-04-12 2022-08-16 Covidien Lp Medical device delivery
US10786377B2 (en) 2018-04-12 2020-09-29 Covidien Lp Medical device delivery
US11123209B2 (en) 2018-04-12 2021-09-21 Covidien Lp Medical device delivery
US11071637B2 (en) 2018-04-12 2021-07-27 Covidien Lp Medical device delivery
US11844914B2 (en) 2018-06-05 2023-12-19 Edwards Lifesciences Corporation Removable volume indicator for syringe
US11779728B2 (en) 2018-11-01 2023-10-10 Edwards Lifesciences Corporation Introducer sheath with expandable introducer
US11413174B2 (en) 2019-06-26 2022-08-16 Covidien Lp Core assembly for medical device delivery systems
KR20230054857A (en) 2020-08-24 2023-04-25 에드워즈 라이프사이언시스 코포레이션 Commissural markers for prosthetic heart valves

Citations (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4649922A (en) * 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4681110A (en) * 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4705517A (en) * 1985-09-03 1987-11-10 Becton, Dickinson And Company Percutaneously deliverable intravascular occlusion prosthesis
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US4760849A (en) * 1985-04-10 1988-08-02 Medinvent S.A. Planar blank and a coil spring manufactured therefrom
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4856516A (en) * 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4877030A (en) * 1988-02-02 1989-10-31 Andreas Beck Device for the widening of blood vessels
US4886062A (en) * 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4907336A (en) * 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4923464A (en) * 1985-09-03 1990-05-08 Becton, Dickinson And Company Percutaneously deliverable intravascular reconstruction prosthesis
US4950227A (en) * 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4969890A (en) * 1987-07-10 1990-11-13 Nippon Zeon Co., Ltd. Catheter
US4990151A (en) * 1988-09-28 1991-02-05 Medinvent S.A. Device for transluminal implantation or extraction
US4990155A (en) * 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5007926A (en) * 1989-02-24 1991-04-16 The Trustees Of The University Of Pennsylvania Expandable transluminally implantable tubular prosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US5059211A (en) * 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5078726A (en) * 1989-02-01 1992-01-07 Kreamer Jeffry W Graft stent and method of repairing blood vessels
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5092841A (en) * 1990-05-17 1992-03-03 Wayne State University Method for treating an arterial wall injured during angioplasty
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US5108417A (en) * 1990-09-14 1992-04-28 Interface Biomedical Laboratories Corp. Anti-turbulent, anti-thrombogenic intravascular stent
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5116309A (en) * 1989-01-25 1992-05-26 Coll Milton E Ureteral stent-catheter system having varying diameter stent
US5116318A (en) * 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
US5122154A (en) * 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5135536A (en) * 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5147385A (en) * 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5163952A (en) * 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US5171262A (en) * 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5192297A (en) * 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5234457A (en) * 1991-10-09 1993-08-10 Boston Scientific Corporation Impregnated stent
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5348538A (en) * 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5358487A (en) * 1993-10-15 1994-10-25 Cordis Corporation Frangible balloon catheter
US5403341A (en) * 1994-01-24 1995-04-04 Solar; Ronald J. Parallel flow endovascular stent and deployment apparatus therefore
US5447497A (en) * 1992-08-06 1995-09-05 Scimed Life Systems, Inc Balloon catheter having nonlinear compliance curve and method of using
US5470313A (en) * 1994-02-24 1995-11-28 Cardiovascular Dynamics, Inc. Variable diameter balloon dilatation catheter
US5556383A (en) * 1994-03-02 1996-09-17 Scimed Lifesystems, Inc. Block copolymer elastomer catheter balloons
US5632760A (en) * 1994-10-20 1997-05-27 Cordis Corporation Balloon catheter for stent implantation
US5645560A (en) * 1995-12-15 1997-07-08 Cardiovascular Dynamics, Inc. Fixed focal balloon for interactive angioplasty and stent implantation
US5695498A (en) * 1996-02-28 1997-12-09 Numed, Inc. Stent implantation system
US5738901A (en) * 1993-09-20 1998-04-14 Scimed Life Systems, Inc. Catheter balloon with retraction coating
US5749851A (en) * 1995-03-02 1998-05-12 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5836965A (en) * 1994-10-19 1998-11-17 Jendersee; Brad Stent delivery and deployment method
US5843116A (en) * 1996-05-02 1998-12-01 Cardiovascular Dynamics, Inc. Focalized intraluminal balloons
US6024752A (en) * 1998-05-11 2000-02-15 Scimed Life Systems, Inc. Soft flexible tipped balloon
US6027510A (en) * 1997-12-08 2000-02-22 Inflow Dynamics Inc. Stent delivery system
US6048350A (en) * 1999-06-14 2000-04-11 Scimed Life Systems, Inc. Segmented balloon delivery system
US6120523A (en) * 1994-02-24 2000-09-19 Radiance Medical Systems, Inc. Focalized intraluminal balloons
US6200325B1 (en) * 1999-03-31 2001-03-13 Advanced Cardiovascular Systems, Inc. Balloon catheter and stent deploying catheter system
US6280412B1 (en) * 1999-06-17 2001-08-28 Scimed Life Systems, Inc. Stent securement by balloon modification
US6315790B1 (en) * 1999-06-07 2001-11-13 Scimed Life Systems, Inc. Radiopaque marker bands
US6387118B1 (en) * 2000-04-20 2002-05-14 Scimed Life Systems, Inc. Non-crimped stent delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233590T2 (en) 1991-09-12 2006-08-03 Advanced Cardiovascular Systems, Inc., Santa Clara In a limited range elastically stretchable inflatable object
JP3968444B2 (en) * 1996-08-23 2007-08-29 ボストン サイエンティフィック サイムド,インコーポレイテッド Stent delivery mechanism with stent fixation device

Patent Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954126A (en) * 1982-04-30 1990-09-04 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4954126B1 (en) * 1982-04-30 1996-05-28 Ams Med Invent S A Prosthesis comprising an expansible or contractile tubular body
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4760849A (en) * 1985-04-10 1988-08-02 Medinvent S.A. Planar blank and a coil spring manufactured therefrom
US4923464A (en) * 1985-09-03 1990-05-08 Becton, Dickinson And Company Percutaneously deliverable intravascular reconstruction prosthesis
US4705517A (en) * 1985-09-03 1987-11-10 Becton, Dickinson And Company Percutaneously deliverable intravascular occlusion prosthesis
US4776337A (en) * 1985-11-07 1988-10-11 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4776337B1 (en) * 1985-11-07 2000-12-05 Cordis Corp Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4681110A (en) * 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4649922A (en) * 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4907336A (en) * 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5059211A (en) * 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4969890A (en) * 1987-07-10 1990-11-13 Nippon Zeon Co., Ltd. Catheter
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4886062A (en) * 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4877030A (en) * 1988-02-02 1989-10-31 Andreas Beck Device for the widening of blood vessels
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US4990151A (en) * 1988-09-28 1991-02-05 Medinvent S.A. Device for transluminal implantation or extraction
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4950227A (en) * 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4856516A (en) * 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US5116309A (en) * 1989-01-25 1992-05-26 Coll Milton E Ureteral stent-catheter system having varying diameter stent
US5078726A (en) * 1989-02-01 1992-01-07 Kreamer Jeffry W Graft stent and method of repairing blood vessels
US5007926A (en) * 1989-02-24 1991-04-16 The Trustees Of The University Of Pennsylvania Expandable transluminally implantable tubular prosthesis
US4990155A (en) * 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5116318A (en) * 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US5171262A (en) * 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5147385A (en) * 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5092841A (en) * 1990-05-17 1992-03-03 Wayne State University Method for treating an arterial wall injured during angioplasty
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5122154A (en) * 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5108417A (en) * 1990-09-14 1992-04-28 Interface Biomedical Laboratories Corp. Anti-turbulent, anti-thrombogenic intravascular stent
US5163952A (en) * 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
US5135536A (en) * 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5234457A (en) * 1991-10-09 1993-08-10 Boston Scientific Corporation Impregnated stent
US5192297A (en) * 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5447497A (en) * 1992-08-06 1995-09-05 Scimed Life Systems, Inc Balloon catheter having nonlinear compliance curve and method of using
US5348538A (en) * 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5738901A (en) * 1993-09-20 1998-04-14 Scimed Life Systems, Inc. Catheter balloon with retraction coating
US5358487A (en) * 1993-10-15 1994-10-25 Cordis Corporation Frangible balloon catheter
US5403341A (en) * 1994-01-24 1995-04-04 Solar; Ronald J. Parallel flow endovascular stent and deployment apparatus therefore
US5470313A (en) * 1994-02-24 1995-11-28 Cardiovascular Dynamics, Inc. Variable diameter balloon dilatation catheter
US20030028211A1 (en) * 1994-02-24 2003-02-06 Michael Crocker Focalized stent implantation
US6120523A (en) * 1994-02-24 2000-09-19 Radiance Medical Systems, Inc. Focalized intraluminal balloons
US5556383A (en) * 1994-03-02 1996-09-17 Scimed Lifesystems, Inc. Block copolymer elastomer catheter balloons
US5836965A (en) * 1994-10-19 1998-11-17 Jendersee; Brad Stent delivery and deployment method
US5632760A (en) * 1994-10-20 1997-05-27 Cordis Corporation Balloon catheter for stent implantation
US5980532A (en) * 1995-03-02 1999-11-09 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5749851A (en) * 1995-03-02 1998-05-12 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5645560A (en) * 1995-12-15 1997-07-08 Cardiovascular Dynamics, Inc. Fixed focal balloon for interactive angioplasty and stent implantation
US6409741B1 (en) * 1995-12-15 2002-06-25 Adiance Medical Systems, Inc. Focalized intraluminal balloons
US5695498A (en) * 1996-02-28 1997-12-09 Numed, Inc. Stent implantation system
US5843116A (en) * 1996-05-02 1998-12-01 Cardiovascular Dynamics, Inc. Focalized intraluminal balloons
US6027510A (en) * 1997-12-08 2000-02-22 Inflow Dynamics Inc. Stent delivery system
US6024752A (en) * 1998-05-11 2000-02-15 Scimed Life Systems, Inc. Soft flexible tipped balloon
US6200325B1 (en) * 1999-03-31 2001-03-13 Advanced Cardiovascular Systems, Inc. Balloon catheter and stent deploying catheter system
US6315790B1 (en) * 1999-06-07 2001-11-13 Scimed Life Systems, Inc. Radiopaque marker bands
US6048350A (en) * 1999-06-14 2000-04-11 Scimed Life Systems, Inc. Segmented balloon delivery system
US6280412B1 (en) * 1999-06-17 2001-08-28 Scimed Life Systems, Inc. Stent securement by balloon modification
US6432080B2 (en) * 1999-06-17 2002-08-13 Scimed Life Systems, Inc Stent securement by balloon modification
US6387118B1 (en) * 2000-04-20 2002-05-14 Scimed Life Systems, Inc. Non-crimped stent delivery system

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040093062A1 (en) * 2001-03-22 2004-05-13 Hendrik Glastra Assembly with therapeutic action
US20080125706A1 (en) * 2006-08-18 2008-05-29 Derek Sutermeister Electrically actuated annelid
US9242073B2 (en) * 2006-08-18 2016-01-26 Boston Scientific Scimed, Inc. Electrically actuated annelid
US20080086192A1 (en) * 2006-10-10 2008-04-10 Boston Scientific Scimed, Inc. Stent protector design
US10729526B2 (en) 2006-10-10 2020-08-04 Boston Scientific Scimed, Inc. Stent protector design
US9814557B2 (en) 2006-10-10 2017-11-14 Boston Scientific Scimed, Inc. Stent protector design
US9216101B2 (en) 2007-07-10 2015-12-22 Boston Scientific Scime, Inc. Dual taper stent protector
US20090018634A1 (en) * 2007-07-10 2009-01-15 Boston Scientific Scimed, Inc. Dual taper stent protector
US20090018640A1 (en) * 2007-07-10 2009-01-15 Boston Scientific Scimed, Inc. Dual Taper Stent Protector
US9655755B2 (en) 2007-07-18 2017-05-23 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9833555B2 (en) 2007-07-18 2017-12-05 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9011364B2 (en) 2007-07-18 2015-04-21 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US11364332B2 (en) 2007-07-18 2022-06-21 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US8784355B2 (en) 2007-07-18 2014-07-22 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US20110166497A1 (en) * 2007-07-18 2011-07-07 Enrique Criado Methods and systems for establishing retrograde carotid arterial blood flow
US9259215B2 (en) 2007-07-18 2016-02-16 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US20110034986A1 (en) * 2007-07-18 2011-02-10 Chou Tony M Systems and methods for treating a carotid artery
US10952882B2 (en) 2007-07-18 2021-03-23 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9789242B2 (en) 2007-07-18 2017-10-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US20100280431A1 (en) * 2007-07-18 2010-11-04 Enrique Criado Methods and systems for establishing retrograde carotid arterial blood flow
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US10085864B2 (en) 2007-07-18 2018-10-02 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US10709832B2 (en) 2007-07-18 2020-07-14 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10286139B2 (en) 2007-07-18 2019-05-14 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10426885B2 (en) 2007-07-18 2019-10-01 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10485917B2 (en) 2007-07-18 2019-11-26 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10543307B2 (en) 2007-07-18 2020-01-28 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US10226598B2 (en) 2008-02-05 2019-03-12 Silk Road Medical, Inc. Interventional catheter system and methods
US20090254166A1 (en) * 2008-02-05 2009-10-08 Chou Tony M Interventional catheter system and methods
US9669191B2 (en) 2008-02-05 2017-06-06 Silk Road Medical, Inc. Interventional catheter system and methods
US11364369B2 (en) 2008-02-05 2022-06-21 Silk Road Medical, Inc. Interventional catheter system and methods
WO2015146259A1 (en) * 2014-03-27 2015-10-01 テルモ株式会社 Balloon catheter and method for manufacturing balloon

Also Published As

Publication number Publication date
US20020120320A1 (en) 2002-08-29
US6764504B2 (en) 2004-07-20

Similar Documents

Publication Publication Date Title
US6764504B2 (en) Combined shaped balloon and stent protector
US5749851A (en) Stent installation method using balloon catheter having stepped compliance curve
US6200325B1 (en) Balloon catheter and stent deploying catheter system
US6419685B2 (en) Balloon catheter with stent securement means
US6432080B2 (en) Stent securement by balloon modification
US6264683B1 (en) Stent delivery catheter with bumpers for improved retention of balloon expandable stents
US6602226B1 (en) Low-profile stent delivery system and apparatus
US6663660B2 (en) Stent delivery system having stent securement apparatus
US5639274A (en) Integrated catheter system for balloon angioplasty and stent delivery
US20060161240A1 (en) Catheter for controlled stent delivery
WO1999015106A1 (en) Balloon mounted stent and method therefor
US20030074044A1 (en) Stent delivery system
CA2727676C (en) Bifurcation catheter assembly with dynamic side branch lumen
US6645174B1 (en) Stent delivery system

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION